Literature DB >> 9151722

Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids.

M C Holmes1, K L French, J R Seckl.   

Abstract

Both serotonergic dysfunction and glucocorticoid hypersecretion are implicated in affective and eating disorders. The adverse effects of serotonergic (5-HT)2C receptor activation on mood and food intake, the antidepressant efficacy of 5-HT2 receptor antagonists, and the hyperphagia observed in 5-HT2C receptor knockout mice all suggest a key role for increased 5-HT2C receptor-mediated neurotransmission. Glucocorticoids, however, downregulate 5-HT2C receptor mRNA in the hippocampus, and it is unclear how increased 5-HT2C receptor sensitivity is achieved in the presence of elevated glucocorticoid levels in depression. Here we show a monophasic diurnal rhythm of 5-HT2C receptor mRNA expression in the rat hippocampus that parallels time-dependent variations in 5-HT2C receptor agonist-induced behaviors in open field tests. Rats entrained to chronic food restriction show marked but intermittent corticosterone hypersecretion and maintain an unaltered 5-HT2C receptor mRNA rhythm. The 5-HT2C receptor mRNA rhythm, however, is suppressed by even modest constant elevations of corticosterone (adrenalectomy + pellet) or with elevated corticosterone during the daytime (8 A.M.), whereas a normal rhythm exists in animals that have the same dose of corticosterone in the evening (6 P.M.). Thus, animals showing even a transient daytime corticosterone nadir exhibit normal hippocampal 5-HT2C receptor mRNA rhythms, even in the presence of overt corticosterone hypersecretion. Chronic food restriction also abolishes the normal diurnal variation in hippocampal glucocorticoid receptor (GR) and mineralocorticoid receptor mRNAs and produces, unusually, both elevated corticosterone and increased GR. The mismatch between elevated glucocorticoids and maintained 5-HT2C receptor and increased GR gene expression in the hippocampus provides a new model to dissect mechanisms that may underlie affective and eating disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151722      PMCID: PMC6573558     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

Review 1.  Distribution of serotonin receptors.

Authors:  J M Palacios; C Waeber; D Hoyer; G Mengod
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 2.  Serotonin and the biology of feeding.

Authors:  J E Blundell
Journal:  Am J Clin Nutr       Date:  1992-01       Impact factor: 7.045

3.  Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.

Authors:  D Julius; A B MacDermott; R Axel; T M Jessell
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats.

Authors:  M J Bradbury; A M Strack; M F Dallman
Journal:  Neuroendocrinology       Date:  1993-10       Impact factor: 4.914

5.  Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

Authors:  J L Moreau; F Jenck; J R Martin; S Perrin; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Serotonin receptor gene expression in the rat suprachiasmatic nuclei.

Authors:  A L Roca; D R Weaver; S M Reppert
Journal:  Brain Res       Date:  1993-04-09       Impact factor: 3.252

7.  Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy.

Authors:  F M Jacobsen; E A Mueller; N E Rosenthal; S Rogers; J L Hill; D L Murphy
Journal:  Psychiatry Res       Date:  1994-05       Impact factor: 3.222

8.  Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.

Authors:  G A Kennett; S Lightowler; V de Biasi; N C Stevens; M D Wood; I F Tulloch; T P Blackburn
Journal:  Neuropharmacology       Date:  1994-12       Impact factor: 5.250

9.  Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression.

Authors:  J P Herman; W E Cullinan; S J Watson
Journal:  J Neuroendocrinol       Date:  1994-08       Impact factor: 3.627

10.  Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.

Authors:  I A MacPhee; F A Antoni; D W Mason
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more
  18 in total

1.  Stress-induced changes in corticosteroid receptor expression in primate hippocampus and prefrontal cortex.

Authors:  Paresh D Patel; Maor Katz; Adriaan M Karssen; David M Lyons
Journal:  Psychoneuroendocrinology       Date:  2008-01-28       Impact factor: 4.905

2.  Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions.

Authors:  R Diaz; R W Brown; J R Seckl
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

Review 3.  5-HT-HPA interactions in two models of transgenic mice relevant to major depression.

Authors:  L Lanfumey; C Mannoury La Cour; N Froger; M Hamon
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

4.  Age-related disruptions of circadian rhythm and memory in the senescence-accelerated mouse (SAMP8).

Authors:  Kevin C H Pang; Jonathan P Miller; Ashley Fortress; J Devin McAuley
Journal:  Age (Dordr)       Date:  2006-11-23

5.  Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress.

Authors:  Wen-Gao Jiang; Su-Xia Li; Jian-Feng Liu; Yan Sun; Shuang-Jiang Zhou; Wei-Li Zhu; Jie Shi; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

6.  Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Authors:  Janice M Paterson; Megan C Holmes; Christopher J Kenyon; Roderick Carter; John J Mullins; Jonathan R Seckl
Journal:  Endocrinology       Date:  2006-12-14       Impact factor: 4.736

Review 7.  11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.

Authors:  Caitlin S Wyrwoll; Megan C Holmes; Jonathan R Seckl
Journal:  Front Neuroendocrinol       Date:  2010-12-07       Impact factor: 8.606

8.  Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity.

Authors:  Atsuko Kimura; Paula L Stevenson; Roderick N Carter; Gavin Maccoll; Karen L French; J Paul Simons; Raya Al-Shawi; Valerie Kelly; Karen E Chapman; Megan C Holmes
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

9.  Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice.

Authors:  W John Sheward; Elizabeth S Maywood; Karen L French; Jacqueline M Horn; Michael H Hastings; Jonathan R Seckl; Megan C Holmes; Anthony J Harmar
Journal:  J Neurosci       Date:  2007-04-18       Impact factor: 6.167

10.  Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

Authors:  Amandine Descamps; Colette Rousset; Mark J Millan; Mark Millan; Michael Spedding; Philippe Delagrange; Raymond Cespuglio
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.